⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACRS News
Aclaris Therapeutics, Inc.
Form 8-K
sec.gov
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
ACRS
Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
ACRS
Excess Share Insurance (ESI) Launches Campio™ Powered by Acrisure®
prnewswire.com
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
ACRS
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
globenewswire.com
ACRS
Aclaris Therapeutics to Participate in Two February Healthcare Conferences
globenewswire.com
ACRS
Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid Tumors
prnewswire.com
ACRS